Danaher Co. (NYSE:DHR) Shares Sold by Glenview Trust co

Glenview Trust co trimmed its holdings in Danaher Co. (NYSE:DHR) by 3.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,216 shares of the conglomerate’s stock after selling 552 shares during the quarter. Glenview Trust co’s holdings in Danaher were worth $3,263,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. FMR LLC increased its stake in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Danaher during the fourth quarter worth about $391,172,000. Van ECK Associates Corp raised its stake in Danaher by 6,862.7% during the fourth quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock worth $213,452,000 after purchasing an additional 916,513 shares during the period. Parnassus Investments LLC boosted its holdings in Danaher by 31.8% in the 4th quarter. Parnassus Investments LLC now owns 3,105,388 shares of the conglomerate’s stock valued at $712,842,000 after purchasing an additional 749,136 shares during the last quarter. Finally, Proficio Capital Partners LLC grew its stake in shares of Danaher by 29,287.7% in the 4th quarter. Proficio Capital Partners LLC now owns 588,929 shares of the conglomerate’s stock valued at $135,189,000 after buying an additional 586,925 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on DHR. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Robert W. Baird decreased their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Jefferies Financial Group lowered their price objective on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Danaher Price Performance

Danaher stock opened at $211.09 on Monday. The stock has a market cap of $150.87 billion, a P/E ratio of 39.98, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a fifty day simple moving average of $220.07 and a 200-day simple moving average of $240.45. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the company posted $2.09 earnings per share. Equities analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 24.24%.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.